Nigeria has experienced a notable increase in the utilisation of primary healthcare (PHC) facilities between 2023 and 2025, according to the Coordinating Minister of Health and Social Welfare Muhammad Pate.
Sunu Assurances Nigeria has announced that its shareholders have approved a capital increase of NGN9bn ($6.2m) to meet new statutory capital requirements under a new insurance law.
Manulife and Bupa International have signed a Memorandum of Understanding (MoU) to establish a strategic collaboration in Hong Kong that will provide customers with greater convenience and flexibility in managing their health.
A staggering 86% of men in South Africa do not go for regular health check-ups, which places them at heightened risk of preventable illnesses, including prostate cancer, according to the findings of a nationwide survey by an insurer.
Prudential Vietnam has once again been listed among the Top 100 Sustainable Companies in Vietnam 2025 (CSI100), marking its ninth consecutive appearance on the prestigious ranking.
India's Union Cabinet has approved a Bill which contains a provision to increase the foreign direct investment limit in insurance companies to 100% from the present cap of 74%. The Bill, cleared on 12 December by the Cabinet, covers several other amendments.
China has published its first state-backed catalogue of costly innovative drugs to be covered by private health insurers.
Indonesia is making steady progress toward ensuring everyone can access the health services they need without financial hardship, according to the latest World Health Organization (WHO) and World Bank Group report on universal health coverage (UHC).
Arabia Insurance Company (AIC) has a track record of profitable, albeit volatile, operating performance, with positive results reported in four of the past five years (2020-2024). However, results in 2023 and 2024 have been lacklustre, with the company reporting return-on-equity (ROE) ratios of 1.4% and 3.9%, respectively, AM Best noted.
The National Healthcare Security Administration (NHSA) and the Ministry of Human Resources and Social Security (MoHRSS) have jointly issued China's first-ever innovative drug catalogue designed specifically for commercial health insurance. One objective is to unlock new growth opportunities for the commercial health insurance market.